323 related articles for article (PubMed ID: 32044323)
1. Mesenchymal stem cells as carriers for systemic delivery of oncolytic viruses.
Hadryś A; Sochanik A; McFadden G; Jazowiecka-Rakus J
Eur J Pharmacol; 2020 May; 874():172991. PubMed ID: 32044323
[TBL] [Abstract][Full Text] [Related]
2. Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice.
Morales-Molina Á; Gambera S; Cejalvo T; Moreno R; Rodríguez-Milla MÁ; Perisé-Barrios AJ; García-Castro J
Cancer Immunol Immunother; 2018 Oct; 67(10):1589-1602. PubMed ID: 30066102
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal Stem Cell-Mediated Delivery of an Oncolytic Adenovirus Enhances Antitumor Efficacy in Hepatocellular Carcinoma.
Yoon AR; Hong J; Li Y; Shin HC; Lee H; Kim HS; Yun CO
Cancer Res; 2019 Sep; 79(17):4503-4514. PubMed ID: 31289131
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy.
Mahasa KJ; de Pillis L; Ouifki R; Eladdadi A; Maini P; Yoon AR; Yun CO
Sci Rep; 2020 Jan; 10(1):425. PubMed ID: 31949228
[TBL] [Abstract][Full Text] [Related]
5. Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases.
Leoni V; Gatta V; Palladini A; Nicoletti G; Ranieri D; Dall'Ora M; Grosso V; Rossi M; Alviano F; Bonsi L; Nanni P; Lollini PL; Campadelli-Fiume G
Oncotarget; 2015 Oct; 6(33):34774-87. PubMed ID: 26430966
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells and oncolytic viruses: joining forces against cancer.
Moreno R
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33558278
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in targeting cancer stem cells using oncolytic viruses.
Zhang YN; Wang SB; Song SS; Hu PY; Zhou YC; Mou YP; Mou XZ
Biotechnol Lett; 2020 Jun; 42(6):865-874. PubMed ID: 32166558
[TBL] [Abstract][Full Text] [Related]
8. Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study.
García-Castro J; Alemany R; Cascalló M; Martínez-Quintanilla J; Arriero Mdel M; Lassaletta A; Madero L; Ramírez M
Cancer Gene Ther; 2010 Jul; 17(7):476-83. PubMed ID: 20168350
[TBL] [Abstract][Full Text] [Related]
9. Canine Adipose-Derived Mesenchymal Stem Cells (cAdMSCs) as a "Trojan Horse" in Vaccinia Virus Mediated Oncolytic Therapy against Canine Soft Tissue Sarcomas.
Petrov I; Gentschev I; Vyalkova A; Elashry MI; Klymiuk MC; Arnhold S; Szalay AA
Viruses; 2020 Jul; 12(7):. PubMed ID: 32664672
[TBL] [Abstract][Full Text] [Related]
10. Enhanced antitumor efficacy of an oncolytic adenovirus armed with an EGFR-targeted BiTE using menstrual blood-derived mesenchymal stem cells as carriers.
Barlabé P; Sostoa J; Fajardo CA; Alemany R; Moreno R
Cancer Gene Ther; 2020 May; 27(5):383-388. PubMed ID: 31204390
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells loaded with oncolytic reovirus enhances antitumor activity in mice models of colorectal cancer.
Babaei A; Soleimanjahi H; Soleimani M; Arefian E
Biochem Pharmacol; 2021 Aug; 190():114644. PubMed ID: 34090878
[TBL] [Abstract][Full Text] [Related]
12. Potent antitumor efficacy of human dental pulp stem cells armed with YSCH-01 oncolytic adenovirus.
He X; Yao W; Zhu JD; Jin X; Liu XY; Zhang KJ; Zhao SL
J Transl Med; 2023 Oct; 21(1):688. PubMed ID: 37789452
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas.
Parker Kerrigan BC; Shimizu Y; Andreeff M; Lang FF
Cytotherapy; 2017 Apr; 19(4):445-457. PubMed ID: 28233640
[TBL] [Abstract][Full Text] [Related]
14. Emerging role of oncolytic viruses and stem cells in gene therapy: Should they be integrated?
Tahir M; Ahmad N; Lei D; Ali S
Drug Discov Today; 2022 Aug; 27(8):2244-2251. PubMed ID: 35351608
[TBL] [Abstract][Full Text] [Related]
15. Advanced new strategies for metastatic cancer treatment by therapeutic stem cells and oncolytic virotherapy.
Park GT; Choi KC
Oncotarget; 2016 Sep; 7(36):58684-58695. PubMed ID: 27494901
[TBL] [Abstract][Full Text] [Related]
16. Systemic administration of human mesenchymal stromal cells infected with polymer-coated oncolytic adenovirus induces efficient pancreatic tumor homing and infiltration.
Na Y; Nam JP; Hong J; Oh E; Shin HC; Kim HS; Kim SW; Yun CO
J Control Release; 2019 Jul; 305():75-88. PubMed ID: 31071373
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model.
Rincón E; Cejalvo T; Kanojia D; Alfranca A; Rodríguez-Milla MÁ; Gil Hoyos RA; Han Y; Zhang L; Alemany R; Lesniak MS; García-Castro J
Oncotarget; 2017 Jul; 8(28):45415-45431. PubMed ID: 28525366
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cell carriers enhance antitumor efficacy induced by oncolytic reovirus in acute myeloid leukemia.
Wang X; Yang Y; Wang N; Wu X; Xu J; Zhou Y; Zhao X; He Z
Int Immunopharmacol; 2021 May; 94():107437. PubMed ID: 33571747
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment.
Ghasemi Darestani N; Gilmanova AI; Al-Gazally ME; Zekiy AO; Ansari MJ; Zabibah RS; Jawad MA; Al-Shalah SAJ; Rizaev JA; Alnassar YS; Mohammed NM; Mustafa YF; Darvishi M; Akhavan-Sigari R
Cell Commun Signal; 2023 Feb; 21(1):43. PubMed ID: 36829187
[TBL] [Abstract][Full Text] [Related]
20. The utility of cells as vehicles for oncolytic virus therapies.
Russell SJ; Peng KW
Curr Opin Mol Ther; 2008 Aug; 10(4):380-6. PubMed ID: 18683103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
